Hologic Stock Performance
| HOLX Stock | USD 76.71 0.48 0.62% |
Hologic has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 0.8, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Hologic's returns are expected to increase less than the market. However, during the bear market, the loss of holding Hologic is expected to be smaller as well. Hologic right now retains a risk of 1.14%. Please check out Hologic maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if Hologic will be following its current trending patterns.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Hologic are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong essential indicators, Hologic is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (0.41) | Five Day Return 1.84 | Year To Date Return 6.09 | Ten Year Return 270.82 | All Time Return 3.1 K |
Last Split Factor 2:1 | Last Split Date 2008-04-03 |
1 | Baker Avenue Asset Management LP Boosts Stock Position in Hologic, Inc. | 03/07/2024 |
2 | Disposition of 90 shares by Scott Garrett of Hologic at 26.74 subject to Rule 16b-3 | 03/14/2024 |
3 | Here is What to Know Beyond Why Hologic, Inc. is a Trending Stock | 03/15/2024 |
4 | Performance Comparison Abbott Laboratories And Competitors In Health Care Equipment Supplies Industry | 03/27/2024 |
5 | Will Hologic Beat Estimates Again in Its Next Earnings Report | 04/03/2024 |
6 | Those who invested in Hologic five years ago are up 63 | 04/04/2024 |
7 | Hologic, Inc. Is a Trending Stock Facts to Know Before Betting on It | 04/08/2024 |
8 | Cellulite Treatment Market To Reach USD 3.9 Billion By 2032, Report By DataHorizzon Research | 04/11/2024 |
9 | Hologic Increases Despite Market Slip Heres What You Need to Know | 04/15/2024 |
10 | Hologic to Report Q2 Earnings Whats in the Cards | 04/17/2024 |
11 | Biopsy Devices Market Analysis, Size, Global Forecast Report 2024-2030 - Increased Demand for Minimally Invasive Diagnostic Techniques | 04/19/2024 |
12 | 3.84 Bn Biopsy Devices Market, Size, Global Forecast Report 2024-2030 Featuring Cardinal Health, Hologic, Danaher, BD and Co, Boston Scientific, Medtronic, Olym... | 04/23/2024 |
| Begin Period Cash Flow | 2.3 B | |
| Total Cashflows From Investing Activities | -152.1 M |
Hologic |
Hologic Relative Risk vs. Return Landscape
If you would invest 7,414 in Hologic on January 25, 2024 and sell it today you would earn a total of 257.00 from holding Hologic or generate 3.47% return on investment over 90 days. Hologic is currently generating 0.0605% in daily expected returns and assumes 1.137% risk (volatility on return distribution) over the 90 days horizon. In different words, 10% of stocks are less volatile than Hologic, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Hologic Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Hologic's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Hologic, and traders can use it to determine the average amount a Hologic's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0532
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | HOLX | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.14 actual daily | 10 90% of assets are more volatile |
Expected Return
| 0.06 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average Hologic is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Hologic by adding it to a well-diversified portfolio.
Hologic Fundamentals Growth
Hologic Stock prices reflect investors' perceptions of the future prospects and financial health of Hologic, and Hologic fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hologic Stock performance.
| Return On Equity | 0.11 | ||||
| Return On Asset | 0.0649 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 18.53 B | ||||
| Shares Outstanding | 234.73 M | ||||
| Price To Earning | 10.21 X | ||||
| Price To Book | 3.90 X | ||||
| Price To Sales | 4.57 X | ||||
| Revenue | 4.03 B | ||||
| Gross Profit | 2.48 B | ||||
| EBITDA | 1.2 B | ||||
| Net Income | 456 M | ||||
| Cash And Equivalents | 2.39 B | ||||
| Cash Per Share | 9.59 X | ||||
| Total Debt | 2.82 B | ||||
| Debt To Equity | 0.57 % | ||||
| Current Ratio | 3.90 X | ||||
| Book Value Per Share | 19.84 X | ||||
| Cash Flow From Operations | 1.05 B | ||||
| Earnings Per Share | 2.11 X | ||||
| Market Capitalization | 18.12 B | ||||
| Total Asset | 9.14 B | ||||
| Retained Earnings | 2.06 B | ||||
| Working Capital | 2.98 B | ||||
| Current Asset | 137.94 M | ||||
| Current Liabilities | 39.47 M | ||||
About Hologic Performance
To evaluate Hologic Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Hologic generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Hologic Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Hologic market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Hologic's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 132.34 | 117.69 | |
| Return On Tangible Assets | 0.08 | 0.09 | |
| Return On Capital Employed | 0.1 | 0.08 | |
| Return On Assets | 0.06 | 0.03 | |
| Return On Equity | 0.08 | 0.09 |
Things to note about Hologic performance evaluation
Checking the ongoing alerts about Hologic for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hologic help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from businesswire.com: 3.84 Bn Biopsy Devices Market, Size, Global Forecast Report 2024-2030 Featuring Cardinal Health, Hologic, Danaher, BD and Co, Boston Scientific, Medtronic, Olympus, and CONMED - ResearchAndMarkets.com |
- Analyzing Hologic's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hologic's stock is overvalued or undervalued compared to its peers.
- Examining Hologic's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Hologic's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hologic's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Hologic's stock. These opinions can provide insight into Hologic's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Hologic Stock analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Hologic's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hologic. If investors know Hologic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hologic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.373 | Earnings Share 2.11 | Revenue Per Share 16.228 | Quarterly Revenue Growth (0.06) | Return On Assets 0.0649 |
The market value of Hologic is measured differently than its book value, which is the value of Hologic that is recorded on the company's balance sheet. Investors also form their own opinion of Hologic's value that differs from its market value or its book value, called intrinsic value, which is Hologic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hologic's market value can be influenced by many factors that don't directly affect Hologic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hologic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hologic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hologic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.